5590 results
Refine Your Search
LCK-targeted Therapy in T cell Acute Lymphoblastic Leukemia
acute lymphoblastic leukemia () is a highly aggressive leukemia in adults with -year survival rate of only about % in patients with relapsed/refractor…
Behind the breakthroughs: A conversation with Carol Gallagher, PharmD
When you hear the word breakthrough, you might imagine a single eureka moment—a discovery that suddenly changes everything. But in blood cancer resear…
Blog
Targeting Unmet Needs For B-cell Lymphomas
Over the past year, we explored whether there is a biological basis that helps explain why African and African American patients typically present wit…
A Phase 2 Open Label Trial of Sonrotoclax in Combination With Zanubrutinib in Patients With Relapsed/Refractory Hairy Cell Leukaemia
Hairy Cell Leukemia (HCL) is a rare blood cancer that affects white blood cells. The usual first treatment is with drugs called purine analogs (PAs). …
Surviving Survivorship: Managing Life During and After a Cancer Diagnosis
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Blood Cancer United Lights The Night: Leaders Advancing Research and Community Impact
Across the country, leaders are stepping up through Light The Night to bring hope, funding and community to families affected by blood cancer.
Blood Cancer
Get Involved
News Release
FDA Approves Oral Combo Treatment for Older Adults with Newly Diagnosed AML
“Older adults make up the majority of people diagnosed with AML, and unfortunately many are not eligible for or cannot tolerate intensive chemotherapy…
News Release
New Treatment Available to Treat People with Mantle Cell Lymphoma
“Sonrotoclax is the first inhibitor now available specifically for MCL. We celebrate the availability of new treatments that extend and improve the …
News Release
Identifying Prognostic Markers of Relapse in Hairy Cell Leukemia (HCL) and HCL-Variant by Profiling Mutated Blood Stem Cells and Fibrosis Pathways
This collaborative program investigates why Hairy Cell Leukemia (HCL) and its variant often relapse despite effective therapies and why fibrosis freq…
Gerlinde Wernig
Gerlinde Wernig, M.D. is an Associate Professor of Pathology at Stanford University and a world expert on fibrosis and blood cancers. She the JAK2 V6…
Living with blood cancer: A broader definition of survivorship
“Survivor” is a loaded word for many people living with cancer. After a cancer diagnosis, big feelings come up. Fear. Sadness. Confusion. Even determ…
Blog
Blood Cancer United’s Therapy Acceleration Program Receives $1M Grant from Blood Cancer UK
Blood Cancer United is actively growing TAP to increase its portfolio and become while continuing to advance the organization's mission. The grant fr…
News Release
Blood Cancer United Opens Applications for the Equity In Access Research Program
Blood Cancer United is now accepting Letters of Intent for its Equity in Access Research Program through September , . The Request for Proposals invi…
News Release
Virtual MDS Support Group - Illinois
The group will address specific issues related to a blood cancer diagnosis and will provide an opportunity for attendees to discuss concerns, anxietie…
Caregiver Support Group - New Haven - 3rd Thursday
This group is open to Yale New Haven patients only.The group will address specific issues related to a blood cancer diagnosis and will provide an oppo…
Loxley
In early September of , my son started to complain of back pain. I took him to the pediatrician, where he was assessed and a multiview was ordered. I…
Dare 2 Dream
Stories
Oakley
Oakley was a typical - going to gymnastics and play dates with her friends until a week after her third birthday when she began to decline very quick…
Dare 2 Dream
Stories
Stacey
In the summer of , just before my 12th birthday, I was feeling tired all the time, didn’t have much of an appetite, and would come home from camp and …
Dare 2 Dream
Stories
Blood Cancer United Data at 2026 ASCO and EHA Highlight Beat AML Progress, Patient Experience Insights and Access Barriers
Blood Cancer researchers will present findings spanning novel treatment approaches and optimization strategies, access and cost barriers, and effort…
News Release
FDA Approves New Treatment for an Ultra‑Rare, Aggressive Blood Cancer
“This is meaningful for patients with BPDCN, where choices have historically been limited, especially for those whose disease has relapsed or stopped …
News Release
Sharon
I went to see an endocrinologist for my diabetes diagnosis right after my husband of years passed away. I had four children, and I wanted to make sur…
Stories
Elizabeth
Like many others, being diagnosed with cancer set off an avalanche of mixed emotions, and I traveled down multiple rabbit holes of . It took me about …
Stories
MaryAnn
I was a nursing staff employee at a nursing home in Maryland. I was not feeling well, and I went to the doctor, explaining that I was having pain in m…
Stories
Sky
Emily and Constance entered my life through the narrow doorway of early motherhood, the fragile fellowship when women bind themselves to one another t…
Stories